Sphere Fluidics Cyto-Mine® Chroma – Unmatched Single-Cell Analysis with Multiplexing Power!
Launching Q1 2025, Sphere Fluidics have announced Cyto-Mine® Chroma, the next-generation platform designed to optimise single-cell analysis workflow efficiency with multiplexing capabilities, greater assay flexibility, and a FOUR-colour laser system for deeper analysis. Applications for antibody discovery and cell line development and allows entry into new areas such as cell and gene therapy.
Cyto-Mine® Chroma is a multiplexing-capable, fully automated single cell analysis platform that can encapsulate, analyse, sort, and dispense viable single cells. Leveraging picodroplet technology, single cells are encapsulated in tiny volumes of liquid. Cyto-Mine® Chroma automates incubation of the cells and cellular output, proliferation, and/or interactions can be measured using standard fluor-based assays. This automated system screens millions to tens of millions of viable single cells and simple controls allow users to select and dispense targeted desired cells for downstream outgrowth.
Cyto-Mine® Chroma Features
- Multiplexing Capabilities analyse targets in one step with four-colour laser system. Enable multiple readouts within a single experiment optimising target cell selection
- Automated Single-Cell Analysis with Picodroplet Technology screen and assess millions to tens of millions of single viable cells in a single day
- Target Cell Selection identify and dispense desired viable cells faster and with higher accuracy, cutting project timelines by months
- Pre-loaded workflows and integrated control software ensures ease of use
- Fluor-based readouts allow flexibility in experimental design
Contact Capella Science now on (02) 9575 7512, sales@capellascience.com.au or Sphere Cyto-Mine® Chroma to learn more.
Recent Comments